Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cancer Genet ; 258-259: 7-9, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34225100

RESUMO

Biphenotypic acute leukemias (BAL) are known as a type of leukemia involving cells with myeloid and along with lymphoid origin, in which genomic changes are detected. It has been stated that the most common genomic changes in BAL are t(9;22) and the translocations of the 11q23 region, these anomalies cause poor prognostic effects. We detected trisomy 5 (+5) in addition to the double Ph chromosome in a case where we investigated the genomic changes using molecular and conventional cytogenetic methods. Bone marrow transplantation was planned due to the poor response to prednisone. According to the information we have obtained, our report will be the first article to discuss the aberrations found in addition to the Ph chromosome in BAL and the effect of these aberrations on prognosis. However, the double observation of the Ph chromosome, which has a poor prognostic effect, is expected to affect the prognosis more negatively, this case will contribute to the literature in terms of trisomy 5. We think that more case reports are needed to reveal the anomalies and their prognostic significance in BAL.


Assuntos
Aberrações Cromossômicas , Síndrome de Cri-du-Chat/genética , Rearranjo Gênico , Leucemia Aguda Bifenotípica/genética , Leucemia Aguda Bifenotípica/patologia , Cromossomo Filadélfia , Trissomia/genética , Pré-Escolar , Cromossomos Humanos Par 5/genética , Humanos , Masculino , Prognóstico
2.
Cancer Genet ; 207(3): 87-93, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24674866

RESUMO

The purpose of this study was to determine the frequency of BCL2, BCL6, IGH, TP53, and MYC protein expression and rearrangements of the respective genes in diffuse large B-cell lymphoma (DLBCL) patients and to assess their prognostic values. Samples from 44 patients with DLBCL were evaluated using fluorescence in situ hybridization and immunohistochemical analyses. BCL6 was the most rearranged gene (63.6%), followed by MYC (31.8%), TP53 (22.7%), and BCL2 (18.2%). Multiple rearrangements were detected in 40.9% of the cases. BCL6 was the most expressed protein (78.6%), followed by TP53 (69.04%), BCL2 (59.5%) and MYC (14.3%). Expression of multiple proteins was detected in 67.4% of the cases. BCL2 (P = .003) expression had a significant negative influence on overall survival,whereas BCL6 (P = .014) expression had a significant positive influence. Our results with a different pattern of gene rearrangements and associated protein overexpression indicate the molecular genetic complexity of DLBCLs, which reflects the morphologic, biologic, and clinical heterogeneity of these lymphomas.


Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Biomarcadores Tumorais , Proteínas de Ligação a DNA/genética , Ordem dos Genes , Genes myc , Linfoma Difuso de Grandes Células B/diagnóstico , Prognóstico , Proteína Supressora de Tumor p53/genética , Humanos , Linfoma Difuso de Grandes Células B/genética , Proteínas Proto-Oncogênicas c-bcl-6 , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA